Stay updated on Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page.

Latest updates to the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page
- Check6 days agoChange DetectedThe footer now displays Revision: v3.6.5, updating from v3.6.4. This reflects a small platform update with no visible changes to the study details or page functionality.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedIPD sharing documentation version updated from v3.6.3 to v3.6.4, indicating a newer revision of the study's data-sharing materials.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page footer now shows Revision: v3.6.3, replacing the previous v3.6.2. This reflects a small backend or UI update that does not modify the study details.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page now shows Revision: v3.6.2 in place of Revision: v3.6.0, indicating an updated documentation or UI version reference.SummaryDifference0.0%

- Check71 days agoChange DetectedThe Study Details navigation headers were updated to standardize the Intervention/Treatment label and to add new help sections including 'How to Read a Study Record,' 'Common Questions,' and 'How to Join a Study,' while removing the old 'Intervention / Treatment' header. A recruitment status indicator 'No longer looking for participants' was added, and the site revision label was updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check78 days agoChange DetectedThe page’s revision tag changed from v3.5.4 to v3.5.5, indicating a new release of the page or its underlying components.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page.